Sophocarpine inhibits tumor progression by antagonizing the PI3K/AKT/mTOR signaling pathway in castration-resistant prostate cancer
Objective The objective of this study was to investigate the inhibitory effect of sophocarpine on the progression of castration-resistant prostate cancer (CRPC) and the underlying molecular mechanism. Methods DU145 and PC3 cells (two CRPC cell lines), incubated with different concentrations of sopho...
Main Authors: | Min Weng, Chenghao Shi, Hui Han, Hengyue Zhu, Yanyi Xiao, Hangcheng Guo, Zhixian Yu, Cunzao Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2022-09-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/14042.pdf |
Similar Items
-
A review on the pharmacology, pharmacokinetics and toxicity of sophocarpine
by: Shichao Wei, et al.
Published: (2024-04-01) -
Sophocarpine Alleviates Isoproterenol-Induced Kidney Injury by Suppressing Inflammation, Apoptosis, Oxidative Stress and Fibrosis
by: Wei Zhou, et al.
Published: (2022-11-01) -
Expression of mTOR in normal and pathological conditions
by: A Marques-Ramos, et al.
Published: (2023-07-01) -
Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021-08-01) -
Synthesis and biological evaluation of sophocarpinic acid derivatives as anti-HCV agents
by: Yinghong Li, et al.
Published: (2014-08-01)